Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2013 1
2014 2
2016 1
2017 1
2018 1
2019 2
2020 4
2021 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
Mau-Sørensen M, Gerner-Rasmussen J, Hansen O, Holm B, Nyhus CH, McCulloch T, Nielsen HA, Wedervang K, Rytter C, Jeppesen N, Langer SW. Mau-Sørensen M, et al. Among authors: mcculloch t. Acta Oncol. 2023 Dec;62(12):1979-1982. doi: 10.1080/0284186X.2023.2278173. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37934081 Clinical Trial. No abstract available.
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma.
Haakensen VD, Nowak AK, Ellingsen EB, Farooqi SJ, Bjaanæs MM, Horndalsveen H, Mcculloch T, Grundberg O, Cedres SM, Helland Å. Haakensen VD, et al. Among authors: mcculloch t. J Transl Med. 2021 May 31;19(1):232. doi: 10.1186/s12967-021-02905-3. J Transl Med. 2021. PMID: 34059094 Free PMC article. Clinical Trial.
Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial.
Lutz CM, Knap MM, Hoffmann L, Møller DS, Hansen O, Brink C, Schytte T, Nyhus CH, McCulloch T, Borissova S, Alber M, Khalil AA. Lutz CM, et al. Among authors: mcculloch t. Clin Transl Radiat Oncol. 2020 Nov 26;27:8-14. doi: 10.1016/j.ctro.2020.11.013. eCollection 2021 Mar. Clin Transl Radiat Oncol. 2020. PMID: 33385069 Free PMC article.
High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.
Szejniuk WM, Nielsen MS, Takács-Szabó Z, Pawlowski J, Al-Saadi SS, Maidas P, Bøgsted M, McCulloch T, Frøkjær JB, Falkmer UG, Røe OD. Szejniuk WM, et al. Among authors: mcculloch t. Radiat Oncol. 2021 Jul 15;16(1):131. doi: 10.1186/s13014-021-01857-8. Radiat Oncol. 2021. PMID: 34266462 Free PMC article.
A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC.
Hansen O, Knap MM, Khalil A, Nyhus CH, McCulloch T, Holm B, Brink C, Hoffmann L, Schytte T. Hansen O, et al. Among authors: mcculloch t. Radiother Oncol. 2017 May;123(2):276-281. doi: 10.1016/j.radonc.2017.03.017. Epub 2017 Apr 11. Radiother Oncol. 2017. PMID: 28410809 Clinical Trial.
13 results